Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity

Baranda S Hansen1, Rehana Z Hussain, Amy E Lovett-Racke

  • 1Department of Neurology, UT Southwestern Medical Center, 5323 Harry Hines Blvd. Dallas, TX 75390, USA.

Journal of Neuroimmunology
|December 20, 2005
PubMed

Insights

Infections can worsen Multiple Sclerosis (MS). Pathogen-associated molecular patterns (PAMPs) act as adjuvants to induce Experimental Autoimmune Encephalomyelitis (EAE), an MS model, suggesting a role in T cell priming.

Area of Science:

  • Immunology
  • Neuroscience
  • Microbiology

Background:

  • Infections are known triggers or exacerbators of Multiple Sclerosis (MS).
  • Bacterial and viral agents are implicated in MS pathogenesis.
  • Pathogen-associated molecular patterns (PAMPs) are recognized by host cells via Toll-like receptors (TLRs).

Purpose of the Study:

  • To investigate the role of PAMPs in the animal model of MS, Experimental Autoimmune Encephalomyelitis (EAE).
  • To determine if PAMPs can act as adjuvants in EAE induction.
  • To explore the necessity of TLR signaling in the target organ for EAE development.

Main Methods:

  • Utilized the EAE animal model.
  • Investigated the role of MyD88-dependent PAMPs.
  • Conducted studies with IRAK1-deficient mice.

Main Results:

  • Various MyD88-dependent PAMPs were found to act as adjuvants in inducing EAE.
  • TLR signaling in the target organ was not required for disease development in IRAK1-deficient mice.
  • PAMPs appear crucial for priming autoreactive T cells in EAE.

Conclusions:

  • PAMPs play a significant role in the induction of EAE, potentially through adjuvant activity.
  • The findings suggest PAMPs are important for priming autoreactive T cells in EAE.
  • This mechanism may also be relevant to the pathogenesis of Multiple Sclerosis in humans.

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...